BACKGROUNDPoor accrual to cancer clinical trials may contribute to the lower improvement in survival observed for adolescents and young adults (AYAs) (those aged 15\u201339 years) with cancer. This has been difficult to quantify without reliable mechanisms to link incident cases with study enrollments. Using unique resources available at their National Cancer Institute-designated comprehensive cancer center, the authors compared the percentage of AYAs, children, and older adults enrolled onto cancer clinical trials and determined predictors of enrollment.METHODSPatients diagnosed with cancer from January 2008 through December 2012 at 1 pediatric and 2 adult University of Southern California hospitals were identified through the California C...
Although it is well documented that adolescents and young adults (AYAs) with cancer have low partici...
Purpose:Adolescents with cancer have had less improvement in survival than other populations in the ...
Cancer statistics for adolescents and young adults (AYAs) (aged 15-39 years) are often presented in ...
2018-08-08Cancer is the leading cause of disease-related death for adolescents and young adults (AYA...
BackgroundStagnant outcomes for adolescents and young adults (AYAs) 15-39 years of age with cancer a...
BackgroundFew adolescents and young adults (AYAs, 15-39 years old) enroll onto cancer clinical ...
In the United States, adolescent and young adult (AYA) patients with cancer have the lowest clinical...
Purpose – Adolescents and young adults (AYAs) have experienced slower increases in cancer survival r...
Purpose: Clinical trial enrollment is low among adolescents and young adults (AYAs) with cancer and ...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
PurposeStagnant outcomes for adolescents and young adults (AYAs; 15 to 39 years old) with cancer are...
Brian D Friend,1 Abinav Baweja,2 Gary Schiller,3 Jonathan Bergman,4 Mark S Litwin,4 Jonathan W Goldm...
Despite overall improvement in survival, morbidity, and quality of life of US patients with cancer, ...
BackgroundAdolescents and young adults (AYAs) ages 15 to 39 years with cancer continue to experience...
Abstract Background Both adolescent and young adult (AYA) and Black or African American (hereafter r...
Although it is well documented that adolescents and young adults (AYAs) with cancer have low partici...
Purpose:Adolescents with cancer have had less improvement in survival than other populations in the ...
Cancer statistics for adolescents and young adults (AYAs) (aged 15-39 years) are often presented in ...
2018-08-08Cancer is the leading cause of disease-related death for adolescents and young adults (AYA...
BackgroundStagnant outcomes for adolescents and young adults (AYAs) 15-39 years of age with cancer a...
BackgroundFew adolescents and young adults (AYAs, 15-39 years old) enroll onto cancer clinical ...
In the United States, adolescent and young adult (AYA) patients with cancer have the lowest clinical...
Purpose – Adolescents and young adults (AYAs) have experienced slower increases in cancer survival r...
Purpose: Clinical trial enrollment is low among adolescents and young adults (AYAs) with cancer and ...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
PurposeStagnant outcomes for adolescents and young adults (AYAs; 15 to 39 years old) with cancer are...
Brian D Friend,1 Abinav Baweja,2 Gary Schiller,3 Jonathan Bergman,4 Mark S Litwin,4 Jonathan W Goldm...
Despite overall improvement in survival, morbidity, and quality of life of US patients with cancer, ...
BackgroundAdolescents and young adults (AYAs) ages 15 to 39 years with cancer continue to experience...
Abstract Background Both adolescent and young adult (AYA) and Black or African American (hereafter r...
Although it is well documented that adolescents and young adults (AYAs) with cancer have low partici...
Purpose:Adolescents with cancer have had less improvement in survival than other populations in the ...
Cancer statistics for adolescents and young adults (AYAs) (aged 15-39 years) are often presented in ...